- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05331898
Rational Drug Use Education Parental Attitudes
The Effect Of Rational Drug Use Education Given To Parents On Parental Attitudes
Study Overview
Detailed Description
Type of the Research The study was conducted as a randomized controlled trial with a pretest-posttest design.
Place and Time of the Research The research was conducted between June 2020 and September 2021 in a Family Health Center (FHC) in Erzurum.
Population and Sample of the Research The study's population comprised parents with children aged 0 to 12 who were registered at an Erzurum FHC. Using the probabilistic sampling method, the study sample consisted of 100 parents who came to the FHC on the specified dates and matched the research criteria. Power analysis was used to determine the sample size in the study using the G.Power 3.1.9.2 application. In the power analysis, it was determined that 104 parents should be reached, 52 parents in the experimental group and 52 parents in the control group, with a 95% confidence interval, 80% theoretical power, and 0.5 impact power. At this point, 2 experimental and 2 control parents who did not want to participate in the study were removed from the study, bringing the total number of participants to 100 (50 experimental, 50 control).
Inclusion criteria for the study;
- Being a 0-12 age group child
- Being literate
- Not having any communication problems
- Previous drug use for the child. Data Collection Tools "Parent Introductory Information Form", "Parental Attitude Scale for Rational Drug Use" and "Rational Drug Use Education" were used to collect research data.
Parent Introductory Information Form: In this form, which was prepared by the researcher based on the literature, there are 13 questions in total about age, gender, place of residence of the parents, family type, social security, socioeconomic level, educational status, and occupation, the number of children aged 0-12, the presence of children with chronic diseases, where they most often apply for drug treatment when their child is sick, and the most frequently non-prescribed drugs.
Parental Attitude Scale for Rational Drug Use (PASRDU): It was developed in 2018. The scale consists of 2 sub-dimensions and 40 items. The sub-dimensions of the scale "Correct and Conscious Use" consist of 29 items and "Effective and Safe Use" consists of 11 items. PASRDU is a 5-point Likert-type scale consisting of five questions with the answers "(1) strongly disagree, (2) disagree, (3) indecisive, (4) agree, (5) strongly agree". While 12 of the 40 items in the scale were negative (16,30,31,32,33,34,35,36,37,38,39,40) statements, 28 items consisted of positive statements. The negative items were reverse-scored. The higher the score obtained from the scale, the higher the positive attitude of parents towards rational drug use.
Rational Drug Use Education: An education booklet was created by the researchers based on the literature. What is a drug? What is rational drug use? What are the benefits of rational drug use? What are the principles of rational drug use? What is irrational drug use? What are the main effects of irrational drug use? What are the problems of irrational drug use? Who makes up the rational drug use team? What are the most common errors mothers make when giving their children drugs? What should be known about rational drug use? What should we pay attention to when giving a drug to children? These are some of the questions it contains.
Data Collection Control Group: Initially, control group data were collected. In the first interview, pre-test data were collected by applying the "Parent Introductory Information Form" and "Parental Attitude Scale for Rational Drug Use". It took roughly 15-20 minutes to complete the forms. No education was provided. Covid-19 precautions were taken while collecting data. One month after the pre-test application, the post-test was applied. Post-test data were collected by the telemonitoring method.
Experimental Group: In the first interview, pre-test data were collected by applying the "Parent Introductory Information Form" and "Parental Attitude Scale for Rational Drug Use. It took roughly 15-20 minutes to complete the forms. A PowerPoint presentation developed by the researcher was used to provide rational drug use training. The parents were given the prepared education booklet so that they may utilize it whenever they required it. Covid-19 precautions were taken while collecting data. One month after training, posttest data were collected. Telemonitoring method was used to collect post-test data.
Variables of the Research Dependent Variable: "Parental Attitude Scale for Rational Drug Use" score averages of parents Independent Variable: "Rational Drug Use" education given to parents Control Variable: Introductory characteristics of parents Evaluation of the Data Statistical analysis of the research data was evaluated using the SPSS 22.0 (Statistical Package for Social Science) package program. Continuous variables were given as mean±standard deviation and categorical variables as numbers and percentages. The student's t-test was used for two-group comparisons of normally distributed quantitative data. A Paired-Sample t-test was used to compare the normally distributed scale scores before and after education. Additionally, differences between categorical variables were analyzed by Chi-square analysis. The significance level was set as p˂0.05.
Ethical Principles of the Research Ethical approval of the Ethics Committee was obtained for the study. The research group's parents were informed about the study's purpose, their questions were answered, and their verbal and written consents were obtained. The parents were informed that the information they supplied would be kept private and would not be shared with anyone else and that they had the right to withdraw from the study at any time. Since the use of the human phenomenon requires the protection of individual rights, the relevant ethical principles "Principle of Informed Consent", "Principle of Volunteering" and "Principle of Protection of Confidentiality" were fulfilled in the research.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Center
-
Erzurum, Center, Turkey, 25240
- Ataturk University Nursing of Faculty
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being a 0-12 age group child
- Being literate
- Not having any communication problems
- Previous drug use for the child.
Exclusion Criteria:
- 0-12 age group without children
- Being illiterate
- Having communication problems
- The child does not use drugs.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Education Group
increase the rational drug use of the parents.
|
the education given increased the rational drug use of the parents.
|
|
No Intervention: control
PARENTS CANNOT USE RATIONAL MEDICATION ON THEIR CHILDREN
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parental Attitude Scale for Rational Drug Use
Time Frame: 15 MONTHS
|
It was developed in 2018.
The scale consists of 2 sub-dimensions and 40 items.
The sub-dimensions of the scale "Correct and Conscious Use" consist of 29 items and "Effective and Safe Use" consists of 11 items.
PASRDU is a 5-point Likert-type scale consisting of five questions with the answers "(1) strongly disagree, (2) disagree, (3) indecisive, (4) agree, (5) strongly agree".
While 12 of the 40 items in the scale were negative (16,30,31,32,33,34,35,36,37,38,39,40) statements, 28 items consisted of positive statements.
The negative items were reverse-scored.
The higher the score obtained from the scale, the higher the positive attitude of parents towards rational drug use.
|
15 MONTHS
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: ARZU SARIALİOĞLU, PHD, Ataturk University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- B.30.2.ATA.0.01.00/502
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Disorder
-
University of California, DavisCompleted
-
University of California, DavisCompletedPediatric DisorderUnited States
-
Necmettin Erbakan UniversityRecruitingPelvic Floor Muscle Training and Dynamic Neuromuscular Stabilization Exercises in Pediatric PatientsPediatric Disorder | UrologyTurkey (Türkiye)
-
Children's Hospital of Fudan UniversityCompleted
-
Children's Hospital of Fudan UniversityCompletedPediatric Disorder | Capsule EndoscopyChina
-
CoapTechChildren's Hospital of Philadelphia; Columbia University; Children's National...RecruitingGastrostomy | Pediatric Disorder | Ultrasound | Gastrostomy ComplicationsUnited States
-
Massachusetts General HospitalTerminatedPediatric Bipolar Disorder | Pediatric OCDUnited States
-
Ataturk UniversityCompleted
-
Baylor Research InstituteBaylor Scott and White HealthNot yet recruiting
-
Boston Children's HospitalRecruitingPediatric ALL | Motility DisorderUnited States
Clinical Trials on Education
-
Erzincan UniversityCompletedQuality of Life | Nursing Caries | Breastfeeding | Postpartum | Nursing Model | Levine Conservation Model
-
Simon Fraser UniversityNatural Sciences and Engineering Research Council, CanadaNot yet recruiting
-
University of Social Sciences and Humanities, WarsawNational Science Centre, PolandRecruiting
-
Marmara UniversityCompleted
-
Pamukkale UniversityCompletedBreastfeeding | ImmigrantTurkey
-
University of MostarUnknownPain Score | Apgar Score | Mental Health Issue | Delivery Mode | Breastfeeding RateBosnia and Herzegovina
-
Centro de Endocrinologia Experimental y AplicadaNational Council of Scientific and Technical Research, ArgentinaCompletedType 2 DiabetesArgentina
-
Mclean HospitalCompleted
-
University of South FloridaNational Cancer Institute (NCI)WithdrawnPediatric CancerUnited States
-
Oregon Health and Science UniversityEnrolling by invitation